Cardinal Health stock costs EUR 212.10 at USD 55.6 billion market cap

Published on 10/09/2026 at 19:01 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Cardinal Health stock was EUR 212.10 on October 9, 2026 after EUR 213.15. Fiscal 2027 first-quarter results are due November 5.

Key points in brief

Cardinal Health stock was EUR 212.10 at Lang & Schwarz on October 9, 2026, minus 0.49 percent versus the prior close.
The NYSE quote was USD 237.60 at 1:00 p.m. EDT, while the 52-week range was USD 151.87 to USD 258.30.
Market capitalization was USD 55.6 billion and the P/E ratio was 32.82 on October 9, 2026.
Nineteen analysts held a Moderate Buy consensus with an average target of USD 266.56.
Fiscal 2027 first-quarter results are scheduled for November 5, 2026.

Schwarzweiß-Reportage an der Verladerampe eines Pharma-Distributionszentrums — Cardinal Health Inc. zeigt eine SW-Reportage der Verladerampe im Pharma-Lager ISIN US14149Y1082, Illustration mit AI erstellt.

At 6:55 p.m. CEST on October 9, 2026, Cardinal Health (ISIN US14149Y1082) was trading at EUR 212.10 at Lang & Schwarz, minus 0.49 percent versus the prior close of EUR 213.15. The company had a market capitalization of USD 55.6 billion and a P/E ratio of 32.82 on the same date.

NYSE price stays inside range

On the NYSE, Cardinal Health was last at USD 237.60 at 1:00 p.m. EDT on October 9, 2026. The primary-market 52-week range ran from USD 151.87 to USD 258.30, giving the stock a broad valuation frame without mixing the dollar quote with the euro price.

The Lang & Schwarz bid was EUR 211.90 and the ask was EUR 212.30 at 6:55 p.m. CEST. Trading volume was 326,130 shares on the NYSE against an average of 1,886,118 shares, while the primary-market quote remained below its 52-week high.

Valuation and analyst consensus

According to MarketBeat on October 9, 2026, 19 analysts held a Moderate Buy consensus, including 16 buy ratings and three holds. The average 12-month target was USD 266.56, while the report cited a USD 239.15 share price.

The same MarketBeat report said Cardinal Health had issued fiscal 2027 adjusted earnings per share guidance of USD 12.40-12.60. It also listed a quarterly dividend of USD 0.5158 per share and an annualized yield of 0.90 percent.

Comparison with peers

Cardinal Health: minus 0.49 percent, P/E 32.82, market capitalization USD 55.6 billion

McKesson (NYSE, USD): plus 0.86 percent, P/E 25.07, market capitalization USD 109.9 billion

Cencora (NYSE, USD): plus 0.61 percent, P/E 24.00, market capitalization USD 62.9 billion

Next results date is set

According to Cardinal Health on October 1, 2026, fiscal 2027 first-quarter results are scheduled for November 5 before the NYSE open, with a webcast at 8:30 a.m. Eastern.

Euro price after the Xetra close

Cardinal Health was trading at EUR 212.10 at Lang & Schwarz on October 9, 2026 at 6:55 p.m. CEST, minus 0.49 percent versus the Lang & Schwarz prior close of EUR 213.15 on October 8, 2026. The further course of trading is shown by the continuously updated real-time quote of Cardinal Health stock.